| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 69 | 2024 | 688 | 16.430 |
Why?
|
| Arthroplasty, Replacement, Hip | 74 | 2023 | 862 | 14.450 |
Why?
|
| Hip Prosthesis | 38 | 2023 | 579 | 8.620 |
Why?
|
| Prosthesis Failure | 30 | 2023 | 541 | 5.750 |
Why?
|
| Knee Prosthesis | 17 | 2024 | 240 | 5.460 |
Why?
|
| Reoperation | 47 | 2024 | 952 | 5.170 |
Why?
|
| Prosthesis Design | 28 | 2023 | 509 | 4.080 |
Why?
|
| Knee Joint | 26 | 2024 | 827 | 3.830 |
Why?
|
| Prosthesis-Related Infections | 16 | 2023 | 222 | 3.770 |
Why?
|
| Postoperative Complications | 22 | 2019 | 997 | 3.690 |
Why?
|
| Retrospective Studies | 53 | 2023 | 3665 | 3.260 |
Why?
|
| Osteoarthritis, Knee | 11 | 2021 | 400 | 3.020 |
Why?
|
| Humans | 147 | 2024 | 31073 | 3.010 |
Why?
|
| Orthopedics | 6 | 2018 | 128 | 2.680 |
Why?
|
| Hip Joint | 11 | 2016 | 408 | 2.480 |
Why?
|
| Middle Aged | 68 | 2021 | 10240 | 2.460 |
Why?
|
| Patient Satisfaction | 8 | 2020 | 310 | 2.370 |
Why?
|
| Aged | 61 | 2023 | 10082 | 2.110 |
Why?
|
| Internship and Residency | 7 | 2019 | 227 | 2.090 |
Why?
|
| Treatment Outcome | 39 | 2023 | 3810 | 2.020 |
Why?
|
| Tantalum | 8 | 2020 | 35 | 2.010 |
Why?
|
| Male | 71 | 2021 | 16499 | 2.000 |
Why?
|
| Female | 71 | 2021 | 17017 | 1.940 |
Why?
|
| Joint Diseases | 4 | 2021 | 114 | 1.860 |
Why?
|
| Arthritis, Infectious | 6 | 2023 | 63 | 1.750 |
Why?
|
| Blood Loss, Surgical | 6 | 2017 | 67 | 1.730 |
Why?
|
| Femoral Fractures | 5 | 2019 | 42 | 1.620 |
Why?
|
| Synovial Fluid | 7 | 2023 | 127 | 1.550 |
Why?
|
| Periprosthetic Fractures | 4 | 2019 | 32 | 1.510 |
Why?
|
| Radiography | 13 | 2017 | 695 | 1.390 |
Why?
|
| Adult | 39 | 2024 | 8950 | 1.390 |
Why?
|
| Aged, 80 and over | 30 | 2023 | 5197 | 1.290 |
Why?
|
| Sutures | 3 | 2015 | 46 | 1.270 |
Why?
|
| Osteotomy | 6 | 2018 | 171 | 1.250 |
Why?
|
| Orthopedic Surgeons | 2 | 2019 | 29 | 1.230 |
Why?
|
| Femur | 13 | 2024 | 402 | 1.220 |
Why?
|
| Tibia | 6 | 2021 | 274 | 1.200 |
Why?
|
| Surgeons | 4 | 2023 | 87 | 1.160 |
Why?
|
| Postoperative Period | 12 | 2020 | 303 | 1.140 |
Why?
|
| Anti-Bacterial Agents | 5 | 2023 | 420 | 1.120 |
Why?
|
| Orthopedic Procedures | 6 | 2019 | 329 | 1.120 |
Why?
|
| Titanium | 9 | 2020 | 196 | 1.120 |
Why?
|
| Obesity, Morbid | 2 | 2020 | 98 | 1.100 |
Why?
|
| Blood Transfusion | 3 | 2017 | 65 | 1.100 |
Why?
|
| Body Mass Index | 8 | 2019 | 453 | 1.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 344 | 1.060 |
Why?
|
| Fracture Fixation, Internal | 4 | 2019 | 75 | 1.020 |
Why?
|
| Clinical Competence | 6 | 2021 | 241 | 1.020 |
Why?
|
| Risk Factors | 15 | 2023 | 2591 | 0.990 |
Why?
|
| Algorithms | 8 | 2022 | 416 | 0.990 |
Why?
|
| Hip Fractures | 3 | 2018 | 34 | 0.970 |
Why?
|
| Follow-Up Studies | 11 | 2020 | 1935 | 0.940 |
Why?
|
| Surgical Wound Infection | 5 | 2018 | 103 | 0.940 |
Why?
|
| Knee Dislocation | 2 | 2015 | 7 | 0.940 |
Why?
|
| Femur Head | 5 | 2023 | 67 | 0.920 |
Why?
|
| United States | 17 | 2022 | 2376 | 0.920 |
Why?
|
| Machine Learning | 5 | 2022 | 63 | 0.910 |
Why?
|
| Osteoarthritis, Hip | 5 | 2018 | 95 | 0.880 |
Why?
|
| Prospective Studies | 13 | 2021 | 1899 | 0.870 |
Why?
|
| Logistic Models | 4 | 2018 | 411 | 0.840 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2012 | 62 | 0.840 |
Why?
|
| Suture Techniques | 2 | 2015 | 145 | 0.820 |
Why?
|
| Arthroplasty, Replacement | 4 | 2021 | 150 | 0.810 |
Why?
|
| Venous Thromboembolism | 2 | 2019 | 40 | 0.790 |
Why?
|
| Metal-on-Metal Joint Prostheses | 3 | 2016 | 54 | 0.760 |
Why?
|
| Operative Time | 5 | 2022 | 85 | 0.750 |
Why?
|
| Education, Medical, Graduate | 3 | 2019 | 88 | 0.730 |
Why?
|
| Knee | 2 | 2017 | 47 | 0.710 |
Why?
|
| Hemostatics | 2 | 2017 | 12 | 0.700 |
Why?
|
| Anticoagulants | 2 | 2019 | 110 | 0.660 |
Why?
|
| Hemostasis, Surgical | 2 | 2016 | 15 | 0.660 |
Why?
|
| Electrocoagulation | 2 | 2016 | 19 | 0.650 |
Why?
|
| Range of Motion, Articular | 8 | 2019 | 737 | 0.650 |
Why?
|
| Mobile Applications | 1 | 2019 | 24 | 0.650 |
Why?
|
| Patellar Ligament | 3 | 2017 | 56 | 0.650 |
Why?
|
| Arthralgia | 3 | 2016 | 133 | 0.650 |
Why?
|
| Hip Dislocation | 1 | 2020 | 68 | 0.640 |
Why?
|
| Preoperative Care | 2 | 2016 | 144 | 0.640 |
Why?
|
| Physician Assistants | 1 | 2019 | 17 | 0.640 |
Why?
|
| Betacoronavirus | 1 | 2020 | 89 | 0.640 |
Why?
|
| Patella | 2 | 2018 | 88 | 0.630 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2016 | 39 | 0.630 |
Why?
|
| Inventions | 1 | 2018 | 2 | 0.620 |
Why?
|
| Entrepreneurship | 1 | 2018 | 3 | 0.620 |
Why?
|
| Patient Care | 1 | 2018 | 34 | 0.620 |
Why?
|
| Research | 2 | 2017 | 54 | 0.610 |
Why?
|
| Femur Head Necrosis | 2 | 2011 | 9 | 0.610 |
Why?
|
| Societies, Medical | 3 | 2018 | 191 | 0.610 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 43 | 0.610 |
Why?
|
| Ambulatory Care | 1 | 2018 | 79 | 0.610 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 101 | 0.600 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 104 | 0.600 |
Why?
|
| Antifibrinolytic Agents | 2 | 2017 | 21 | 0.600 |
Why?
|
| Tranexamic Acid | 2 | 2017 | 21 | 0.590 |
Why?
|
| Medicaid | 2 | 2017 | 39 | 0.590 |
Why?
|
| Pandemics | 1 | 2020 | 274 | 0.590 |
Why?
|
| Aprotinin | 1 | 2017 | 2 | 0.590 |
Why?
|
| Patient Care Bundles | 1 | 2017 | 5 | 0.580 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2017 | 8 | 0.580 |
Why?
|
| Ankle Fractures | 1 | 2017 | 1 | 0.580 |
Why?
|
| Nurse Practitioners | 1 | 2019 | 106 | 0.570 |
Why?
|
| Open Fracture Reduction | 1 | 2017 | 5 | 0.570 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 26 | 0.570 |
Why?
|
| Knee Injuries | 2 | 2017 | 238 | 0.570 |
Why?
|
| Acetabulum | 4 | 2016 | 203 | 0.560 |
Why?
|
| Cobalt | 3 | 2023 | 113 | 0.560 |
Why?
|
| Efficiency | 1 | 2017 | 16 | 0.560 |
Why?
|
| Cost Savings | 2 | 2017 | 34 | 0.560 |
Why?
|
| Bone Cements | 2 | 2016 | 95 | 0.560 |
Why?
|
| Corrosion | 7 | 2023 | 135 | 0.560 |
Why?
|
| Injections, Intra-Articular | 1 | 2017 | 97 | 0.550 |
Why?
|
| Hospital Costs | 1 | 2017 | 69 | 0.550 |
Why?
|
| Argon Plasma Coagulation | 1 | 2016 | 1 | 0.540 |
Why?
|
| Publishing | 1 | 2017 | 42 | 0.540 |
Why?
|
| Staphylococcal Infections | 3 | 2017 | 185 | 0.540 |
Why?
|
| Survivorship | 3 | 2020 | 19 | 0.530 |
Why?
|
| Kaplan-Meier Estimate | 5 | 2018 | 190 | 0.530 |
Why?
|
| Polyethylene | 3 | 2016 | 121 | 0.530 |
Why?
|
| Chromium | 2 | 2013 | 93 | 0.520 |
Why?
|
| Alloys | 2 | 2013 | 96 | 0.520 |
Why?
|
| Cefuroxime | 1 | 2015 | 2 | 0.520 |
Why?
|
| Cefazolin | 1 | 2015 | 5 | 0.520 |
Why?
|
| Cell Count | 1 | 2015 | 98 | 0.510 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 149 | 0.510 |
Why?
|
| Anesthesia, Spinal | 1 | 2015 | 17 | 0.510 |
Why?
|
| Evidence-Based Medicine | 2 | 2014 | 216 | 0.510 |
Why?
|
| Educational Measurement | 2 | 2019 | 61 | 0.500 |
Why?
|
| Anesthesia, Epidural | 1 | 2015 | 25 | 0.500 |
Why?
|
| Anesthesia, General | 1 | 2015 | 30 | 0.500 |
Why?
|
| Biocompatible Materials | 3 | 2017 | 105 | 0.500 |
Why?
|
| Databases, Factual | 5 | 2018 | 354 | 0.480 |
Why?
|
| Time Factors | 9 | 2019 | 1680 | 0.480 |
Why?
|
| Journal Impact Factor | 1 | 2014 | 17 | 0.470 |
Why?
|
| Length of Stay | 4 | 2021 | 339 | 0.470 |
Why?
|
| Surveys and Questionnaires | 6 | 2019 | 1209 | 0.460 |
Why?
|
| Sleep | 1 | 2017 | 322 | 0.460 |
Why?
|
| Medicare | 6 | 2022 | 127 | 0.450 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 42 | 0.450 |
Why?
|
| Hemiarthroplasty | 1 | 2014 | 31 | 0.450 |
Why?
|
| Porosity | 5 | 2020 | 68 | 0.440 |
Why?
|
| Recovery of Function | 5 | 2018 | 298 | 0.410 |
Why?
|
| Osseointegration | 4 | 2017 | 77 | 0.410 |
Why?
|
| Metals | 4 | 2015 | 154 | 0.410 |
Why?
|
| Radiographic Image Enhancement | 1 | 2012 | 16 | 0.400 |
Why?
|
| Health Care Costs | 1 | 2012 | 72 | 0.400 |
Why?
|
| Professional Competence | 1 | 2012 | 41 | 0.390 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2010 | 27 | 0.370 |
Why?
|
| Chromium Alloys | 5 | 2023 | 48 | 0.360 |
Why?
|
| Risk Assessment | 5 | 2018 | 718 | 0.360 |
Why?
|
| Suction | 3 | 2015 | 48 | 0.350 |
Why?
|
| Odds Ratio | 4 | 2018 | 293 | 0.340 |
Why?
|
| Arthropathy, Neurogenic | 1 | 2009 | 1 | 0.340 |
Why?
|
| Exercise Movement Techniques | 1 | 2009 | 1 | 0.330 |
Why?
|
| Patient Readmission | 2 | 2021 | 132 | 0.310 |
Why?
|
| Patient Preference | 2 | 2019 | 37 | 0.310 |
Why?
|
| Demography | 2 | 2019 | 81 | 0.300 |
Why?
|
| Joint Instability | 2 | 2012 | 405 | 0.300 |
Why?
|
| Comorbidity | 4 | 2017 | 508 | 0.300 |
Why?
|
| Quality Improvement | 4 | 2018 | 165 | 0.300 |
Why?
|
| Exercise Therapy | 2 | 2019 | 113 | 0.300 |
Why?
|
| Body Weight | 2 | 2019 | 141 | 0.300 |
Why?
|
| Propensity Score | 2 | 2018 | 36 | 0.290 |
Why?
|
| Risk Adjustment | 2 | 2018 | 12 | 0.290 |
Why?
|
| Linear Models | 2 | 2018 | 273 | 0.290 |
Why?
|
| Physical Therapy Modalities | 2 | 2019 | 78 | 0.280 |
Why?
|
| Wrist | 1 | 2006 | 16 | 0.280 |
Why?
|
| Ganglion Cysts | 1 | 2006 | 8 | 0.280 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 555 | 0.280 |
Why?
|
| Postoperative Care | 2 | 2019 | 132 | 0.280 |
Why?
|
| Prosthesis Fitting | 2 | 2020 | 24 | 0.280 |
Why?
|
| Ossification, Heterotopic | 1 | 2006 | 41 | 0.270 |
Why?
|
| Guided Tissue Regeneration | 1 | 2006 | 10 | 0.270 |
Why?
|
| Ceramics | 2 | 2018 | 25 | 0.260 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 820 | 0.260 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2020 | 434 | 0.260 |
Why?
|
| Humeral Fractures | 1 | 2005 | 23 | 0.250 |
Why?
|
| Current Procedural Terminology | 2 | 2022 | 14 | 0.250 |
Why?
|
| Biomechanical Phenomena | 2 | 2018 | 700 | 0.250 |
Why?
|
| Wounds and Injuries | 2 | 2016 | 43 | 0.240 |
Why?
|
| Shoulder Fractures | 1 | 2005 | 29 | 0.240 |
Why?
|
| Registries | 3 | 2021 | 203 | 0.240 |
Why?
|
| Prostheses and Implants | 1 | 2006 | 171 | 0.240 |
Why?
|
| Calibration | 2 | 2016 | 23 | 0.230 |
Why?
|
| Signal Transduction | 2 | 2016 | 498 | 0.220 |
Why?
|
| Multivariate Analysis | 4 | 2017 | 344 | 0.220 |
Why?
|
| Simulation Training | 2 | 2021 | 43 | 0.220 |
Why?
|
| Elective Surgical Procedures | 2 | 2020 | 43 | 0.210 |
Why?
|
| Arthroplasty | 3 | 2018 | 141 | 0.210 |
Why?
|
| Femoral Neck Fractures | 2 | 2015 | 12 | 0.210 |
Why?
|
| Computer Simulation | 2 | 2021 | 222 | 0.200 |
Why?
|
| Patient Discharge | 3 | 2019 | 164 | 0.200 |
Why?
|
| Denmark | 1 | 2021 | 12 | 0.190 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 13 | 0.190 |
Why?
|
| Surgical Wound | 2 | 2018 | 12 | 0.190 |
Why?
|
| Social Class | 1 | 2021 | 69 | 0.180 |
Why?
|
| Therapeutic Irrigation | 2 | 2019 | 71 | 0.180 |
Why?
|
| Adolescent | 4 | 2018 | 2403 | 0.180 |
Why?
|
| Wound Healing | 4 | 2018 | 174 | 0.180 |
Why?
|
| Joint Prosthesis | 1 | 2021 | 81 | 0.180 |
Why?
|
| Equipment Design | 3 | 2011 | 189 | 0.180 |
Why?
|
| Case-Control Studies | 1 | 2022 | 664 | 0.180 |
Why?
|
| Joint Dislocations | 2 | 2018 | 60 | 0.170 |
Why?
|
| Leukocyte Count | 3 | 2016 | 93 | 0.170 |
Why?
|
| Incidence | 3 | 2017 | 790 | 0.170 |
Why?
|
| Rivaroxaban | 1 | 2019 | 8 | 0.170 |
Why?
|
| Warfarin | 1 | 2019 | 39 | 0.170 |
Why?
|
| Debridement | 2 | 2017 | 105 | 0.170 |
Why?
|
| Quality of Health Care | 2 | 2018 | 146 | 0.160 |
Why?
|
| Inpatients | 2 | 2019 | 150 | 0.160 |
Why?
|
| Text Messaging | 1 | 2019 | 13 | 0.160 |
Why?
|
| Sensitivity and Specificity | 3 | 2023 | 586 | 0.160 |
Why?
|
| Patient Selection | 2 | 2014 | 246 | 0.160 |
Why?
|
| Video Recording | 1 | 2019 | 44 | 0.160 |
Why?
|
| Biomarkers | 3 | 2023 | 734 | 0.160 |
Why?
|
| Health Personnel | 1 | 2020 | 118 | 0.160 |
Why?
|
| Fracture Healing | 3 | 2010 | 41 | 0.160 |
Why?
|
| Child, Preschool | 1 | 2020 | 691 | 0.160 |
Why?
|
| Aspirin | 1 | 2019 | 87 | 0.160 |
Why?
|
| Young Adult | 4 | 2018 | 2061 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 159 | 0.160 |
Why?
|
| Osteophyte | 1 | 2018 | 8 | 0.160 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 29 | 0.160 |
Why?
|
| Health Care Surveys | 1 | 2018 | 68 | 0.160 |
Why?
|
| Arthrometry, Articular | 1 | 2018 | 15 | 0.160 |
Why?
|
| Forecasting | 1 | 2018 | 115 | 0.160 |
Why?
|
| Intellectual Property | 1 | 2018 | 1 | 0.160 |
Why?
|
| Physician-Patient Relations | 1 | 2018 | 42 | 0.160 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2018 | 4 | 0.160 |
Why?
|
| Venous Thrombosis | 2 | 2017 | 45 | 0.160 |
Why?
|
| Concept Formation | 1 | 2018 | 10 | 0.150 |
Why?
|
| Manipulation, Orthopedic | 1 | 2018 | 10 | 0.150 |
Why?
|
| Minimally Invasive Surgical Procedures | 3 | 2012 | 306 | 0.150 |
Why?
|
| Operating Rooms | 1 | 2018 | 13 | 0.150 |
Why?
|
| Guideline Adherence | 1 | 2018 | 68 | 0.150 |
Why?
|
| Mentors | 1 | 2018 | 49 | 0.150 |
Why?
|
| Regression Analysis | 4 | 2022 | 301 | 0.150 |
Why?
|
| Anesthesia | 1 | 2018 | 36 | 0.150 |
Why?
|
| Physical Examination | 1 | 2018 | 118 | 0.150 |
Why?
|
| Patient Education as Topic | 1 | 2019 | 161 | 0.150 |
Why?
|
| Data Collection | 1 | 2018 | 109 | 0.150 |
Why?
|
| Fracture Fixation | 2 | 2015 | 25 | 0.150 |
Why?
|
| Accreditation | 1 | 2017 | 17 | 0.150 |
Why?
|
| Administration, Intravenous | 1 | 2017 | 28 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2017 | 20 | 0.140 |
Why?
|
| Insurance Coverage | 1 | 2017 | 16 | 0.140 |
Why?
|
| Calcium Sulfate | 1 | 2017 | 20 | 0.140 |
Why?
|
| Health Resources | 1 | 2017 | 24 | 0.140 |
Why?
|
| Viscosupplements | 1 | 2017 | 11 | 0.140 |
Why?
|
| Animals | 5 | 2016 | 4720 | 0.140 |
Why?
|
| Preoperative Period | 1 | 2017 | 76 | 0.140 |
Why?
|
| Leg Length Inequality | 1 | 2016 | 12 | 0.140 |
Why?
|
| Workload | 1 | 2017 | 34 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 31 | 0.140 |
Why?
|
| Personality | 1 | 2017 | 68 | 0.140 |
Why?
|
| Hemoglobins | 1 | 2017 | 82 | 0.140 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 64 | 0.140 |
Why?
|
| Pain | 2 | 2019 | 426 | 0.140 |
Why?
|
| Analysis of Variance | 1 | 2017 | 326 | 0.130 |
Why?
|
| Femur Neck | 1 | 2016 | 18 | 0.130 |
Why?
|
| Child | 1 | 2020 | 1431 | 0.130 |
Why?
|
| Activities of Daily Living | 1 | 2020 | 551 | 0.130 |
Why?
|
| Device Removal | 2 | 2016 | 91 | 0.130 |
Why?
|
| Protein Kinase C-delta | 1 | 2016 | 11 | 0.130 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 109 | 0.130 |
Why?
|
| Casts, Surgical | 1 | 2015 | 8 | 0.130 |
Why?
|
| Axons | 1 | 2016 | 37 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2016 | 81 | 0.130 |
Why?
|
| Intraoperative Period | 1 | 2015 | 34 | 0.130 |
Why?
|
| Surgical Flaps | 1 | 2016 | 54 | 0.130 |
Why?
|
| Rupture, Spontaneous | 1 | 2015 | 7 | 0.130 |
Why?
|
| International Normalized Ratio | 1 | 2015 | 24 | 0.130 |
Why?
|
| Chicago | 1 | 2018 | 941 | 0.130 |
Why?
|
| Tendon Injuries | 1 | 2017 | 205 | 0.120 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 334 | 0.120 |
Why?
|
| Rupture | 1 | 2015 | 121 | 0.120 |
Why?
|
| Ganglia, Spinal | 2 | 2016 | 68 | 0.120 |
Why?
|
| Hemodilution | 1 | 2014 | 2 | 0.120 |
Why?
|
| Laser Coagulation | 1 | 2014 | 6 | 0.120 |
Why?
|
| Blood Component Transfusion | 1 | 2014 | 3 | 0.120 |
Why?
|
| Tourniquets | 1 | 2014 | 3 | 0.120 |
Why?
|
| Pneumonia | 1 | 2015 | 75 | 0.120 |
Why?
|
| Reading | 1 | 2014 | 46 | 0.120 |
Why?
|
| Mass Screening | 1 | 2016 | 186 | 0.120 |
Why?
|
| Hospitalization | 1 | 2017 | 336 | 0.120 |
Why?
|
| Bibliometrics | 1 | 2014 | 28 | 0.120 |
Why?
|
| Age Factors | 1 | 2017 | 875 | 0.120 |
Why?
|
| Morbidity | 1 | 2014 | 65 | 0.120 |
Why?
|
| Bandages | 1 | 2013 | 10 | 0.110 |
Why?
|
| ROC Curve | 3 | 2021 | 145 | 0.110 |
Why?
|
| Medical Errors | 1 | 2014 | 29 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2015 | 123 | 0.110 |
Why?
|
| Observer Variation | 1 | 2014 | 118 | 0.110 |
Why?
|
| Allografts | 1 | 2015 | 202 | 0.110 |
Why?
|
| Blood Sedimentation | 3 | 2021 | 65 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 1318 | 0.110 |
Why?
|
| Bone Resorption | 1 | 2014 | 97 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 43 | 0.110 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 128 | 0.110 |
Why?
|
| Double-Blind Method | 1 | 2014 | 499 | 0.110 |
Why?
|
| Bone Remodeling | 1 | 2013 | 46 | 0.110 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2012 | 3 | 0.110 |
Why?
|
| Hypertension | 1 | 2015 | 288 | 0.100 |
Why?
|
| Stainless Steel | 1 | 2012 | 17 | 0.100 |
Why?
|
| Cost-Benefit Analysis | 1 | 2012 | 149 | 0.100 |
Why?
|
| Physicians | 1 | 2014 | 119 | 0.100 |
Why?
|
| Neoplasms | 1 | 2015 | 261 | 0.100 |
Why?
|
| Reimbursement Mechanisms | 1 | 2012 | 14 | 0.100 |
Why?
|
| Osteoarthritis | 1 | 2016 | 384 | 0.100 |
Why?
|
| Cohort Studies | 3 | 2017 | 2046 | 0.090 |
Why?
|
| Arthroscopy | 1 | 2018 | 892 | 0.090 |
Why?
|
| Fractures, Ununited | 1 | 2010 | 19 | 0.090 |
Why?
|
| Nociceptors | 1 | 2010 | 27 | 0.090 |
Why?
|
| Internal Fixators | 1 | 2010 | 53 | 0.090 |
Why?
|
| Spinal Cord | 1 | 2010 | 107 | 0.090 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2012 | 190 | 0.090 |
Why?
|
| Kidney Failure, Chronic | 1 | 2011 | 161 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 1134 | 0.080 |
Why?
|
| Curriculum | 2 | 2021 | 173 | 0.080 |
Why?
|
| Surface Properties | 2 | 2020 | 135 | 0.080 |
Why?
|
| Arthritis, Psoriatic | 1 | 2008 | 19 | 0.080 |
Why?
|
| Bone Screws | 2 | 2008 | 180 | 0.070 |
Why?
|
| Connective Tissue | 1 | 2007 | 26 | 0.070 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2007 | 2 | 0.070 |
Why?
|
| Pain Management | 2 | 2019 | 144 | 0.070 |
Why?
|
| Contraindications | 1 | 2007 | 42 | 0.070 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 370 | 0.070 |
Why?
|
| Materials Testing | 1 | 2007 | 135 | 0.070 |
Why?
|
| Fluoroscopy | 1 | 2007 | 63 | 0.070 |
Why?
|
| Sports | 1 | 2007 | 47 | 0.070 |
Why?
|
| Guidelines as Topic | 1 | 2007 | 71 | 0.070 |
Why?
|
| Prognosis | 2 | 2008 | 924 | 0.070 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2008 | 132 | 0.070 |
Why?
|
| Bone Nails | 2 | 2020 | 17 | 0.070 |
Why?
|
| Muscle Strength | 1 | 2007 | 136 | 0.070 |
Why?
|
| Walking | 1 | 2008 | 258 | 0.060 |
Why?
|
| Injury Severity Score | 1 | 2005 | 14 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2005 | 14 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 331 | 0.060 |
Why?
|
| Lower Extremity | 1 | 2024 | 40 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2008 | 1507 | 0.060 |
Why?
|
| Athletic Injuries | 1 | 2005 | 180 | 0.050 |
Why?
|
| Vitallium | 1 | 2023 | 27 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2005 | 489 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2016 | 149 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2021 | 322 | 0.050 |
Why?
|
| Finite Element Analysis | 1 | 2020 | 50 | 0.040 |
Why?
|
| Arthrodesis | 1 | 2020 | 45 | 0.040 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2019 | 15 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2020 | 173 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 109 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 7 | 0.040 |
Why?
|
| Pain Perception | 1 | 2019 | 6 | 0.040 |
Why?
|
| Early Ambulation | 1 | 2019 | 20 | 0.040 |
Why?
|
| Learning Curve | 1 | 2019 | 19 | 0.040 |
Why?
|
| Narcotics | 1 | 2019 | 37 | 0.040 |
Why?
|
| Mentoring | 1 | 2019 | 30 | 0.040 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2018 | 10 | 0.040 |
Why?
|
| Data Mining | 1 | 2017 | 4 | 0.040 |
Why?
|
| Hand | 1 | 2018 | 45 | 0.040 |
Why?
|
| Drainage | 1 | 2018 | 52 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 208 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2017 | 70 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2017 | 35 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2017 | 38 | 0.040 |
Why?
|
| Spine | 1 | 2018 | 132 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 136 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 77 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2017 | 88 | 0.030 |
Why?
|
| Self Concept | 1 | 2016 | 44 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 296 | 0.030 |
Why?
|
| Skin Transplantation | 1 | 2016 | 16 | 0.030 |
Why?
|
| Acute Disease | 1 | 2017 | 232 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 120 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 105 | 0.030 |
Why?
|
| Receptor, trkA | 1 | 2016 | 9 | 0.030 |
Why?
|
| Sensory Receptor Cells | 1 | 2016 | 9 | 0.030 |
Why?
|
| Communication | 1 | 2017 | 120 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 168 | 0.030 |
Why?
|
| Recurrence | 1 | 2017 | 375 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 155 | 0.030 |
Why?
|
| Nerve Growth Factor | 1 | 2016 | 33 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 2016 | 84 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 148 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2015 | 50 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 365 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 120 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 223 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2015 | 150 | 0.030 |
Why?
|
| Occlusive Dressings | 1 | 2014 | 2 | 0.030 |
Why?
|
| Wound Closure Techniques | 1 | 2014 | 10 | 0.030 |
Why?
|
| Bacteriological Techniques | 1 | 2013 | 21 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 409 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1006 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2013 | 21 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 147 | 0.030 |
Why?
|
| California | 1 | 2012 | 31 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 782 | 0.030 |
Why?
|
| Fees and Charges | 1 | 2012 | 8 | 0.030 |
Why?
|
| Bone Malalignment | 1 | 2011 | 20 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 499 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 1681 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2012 | 123 | 0.020 |
Why?
|
| Equipment Failure | 1 | 2010 | 53 | 0.020 |
Why?
|
| Educational Status | 1 | 2012 | 312 | 0.020 |
Why?
|
| Arthritis, Experimental | 1 | 2010 | 132 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 467 | 0.020 |
Why?
|
| Chondrocytes | 1 | 2010 | 208 | 0.020 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2008 | 10 | 0.020 |
Why?
|
| Traction | 1 | 2008 | 30 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 871 | 0.020 |
Why?
|
| Bone Plates | 1 | 2008 | 64 | 0.020 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2007 | 3 | 0.020 |
Why?
|
| Erythrocyte Transfusion | 1 | 2007 | 20 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2008 | 103 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2008 | 360 | 0.020 |
Why?
|
| Internet | 1 | 2007 | 92 | 0.020 |
Why?
|